Provided by Tiger Fintech (Singapore) Pte. Ltd.

VIVA BIOTECH

2.720
-0.080-2.86%
Volume:9.19M
Turnover:25.04M
Market Cap:5.79B
PE:31.74
High:2.830
Open:2.830
Low:2.660
Close:2.800
52wk High:2.930
52wk Low:0.570
Shares:2.13B
HK Float Shares:2.13B
Volume Ratio:0.49
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.086
ROE:5.87%
ROA:2.03%
PB:1.36
PE(LYR):31.74
PS:2.88

Loading ...

Hong Kong Stock Alert | VIVA BIOTECH (01873) Surges Nearly 7% in Afternoon Session as First-Half Gross Margin Improves Significantly with Company's Forward-Looking AI Drug Development Strategy

Stock News
·
Sep 03

Viva Biotech Unveils Breakthrough in Cyclic Peptide Therapeutics, Paving the Way for Drug Discovery Innovation

Reuters
·
Sep 02

Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 20% After Earnings Release, Interim Shareholder Profit Up 4.28% YoY, AI Orders Show Growing Trend

Stock News
·
Aug 29

Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Pharma Industry

Stock Track
·
Aug 29

Stock Track | Viva Biotech Soars 5.15% as AI Drug Development Gains Momentum in Tech Industry

Stock Track
·
Aug 29

Hong Kong Stock Concept Tracking | Tech Giants Pour in Investments as AI Drug Development Commercialization Accelerates (With Concept Stocks)

Stock News
·
Aug 29

Press Release: Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to Positive Growth, New CDMO Commercialization Projects Showed Promising Growth

Dow Jones
·
Aug 28

Viva Biotech Holdings Reports 15.3% Drop in Revenue, Slight Increase in Net Profit for H1 2025; EPS Rises to RMB 0.06

Reuters
·
Aug 28

VIVA Biotech Holdings H1 Capex RMB 38.7 Million

THOMSON REUTERS
·
Aug 28

Hong Kong Stock Movement | VIVA BIOTECH (01873) Surges Over 13% Again as High-Value AI Pharmaceutical Collaborations Emerge Frequently, Institutions Highlight Company's Distinct AI Drug Platform Advantages

Stock News
·
Aug 14

VIVA Biotech Holdings Conducted Annual General Meeting

Reuters
·
Jun 12

VIVA Biotech Holdings Issues Clarification on Connected Transaction with Nanjing Entities

Reuters
·
Jun 04

BRIEF-Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund

Reuters
·
May 28

Viva Biotech's Pharma Unit Passes US FDA Onsite Inspection

MT Newswires Live
·
Mar 28

Press Release: Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D

Dow Jones
·
Mar 27

BRIEF-Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical

Reuters
·
Mar 27

Viva Biotech to Turn to 2024 Profit

MT Newswires Live
·
Mar 14

BRIEF-Viva Biotech Holdings Expects Net Profit Of RMB210 Million To RMB240 Million For 2024

Reuters
·
Mar 13

GF Securities Starts Viva Biotech at Buy with HK$2.41 Price Target

MT Newswires Live
·
Mar 13